# A Study of NeoRecormon (Epoetin Beta) in Patients With Renal Anemia.

> **NCT00440063** · PHASE4 · TERMINATED · sponsor: **Hoffmann-La Roche**

## Conditions studied

- Anemia

## Interventions

- **DRUG:** epoetin beta [NeoRecormon]

## Key facts

- **NCT ID:** NCT00440063
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2007-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00440063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00440063, "A Study of NeoRecormon (Epoetin Beta) in Patients With Renal Anemia.". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT00440063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*